Artecan 120 mg Injection
Price range: $72.00 through $240.00
| Quantity Value | Price | Quantity | Add To Cart |
|---|---|---|---|
| 12 Injections | $180.00 |
|
|
| 24 Injections | $240.00 |
|
|
| 3 Injection | $72.00 |
|
|
| 6 Injection | $120.00 |
|
SKU : N/A
Category : Viral Care
Artecan 120 mg Injection is a potent antimalarial medicine containing artesunate used to treat severe malaria caused by Plasmodium falciparum. It works rapidly to reduce parasite load and improve clinical outcomes when administered by a healthcare professional. (WHO – Malaria Treatment Guidelines)
Artecan 120 mg Injection
Artecan 120 mg Injection is a prescription antimalarial medication widely used for the treatment of severe and complicated malaria, especially infections caused by Plasmodium falciparum — the species most commonly associated with severe disease and death. Artesunate, the active ingredient in Artecan, is a derivative of Artemisia annua (sweet wormwood) and belongs to the artemisinin class of antimalarial agents, which have transformed the clinical management of malaria due to their rapid and potent action against the parasite.
This injectable formulation is a critical option in clinical settings where oral medications are not practical, such as in patients who are vomiting, unconscious, or unable to take oral therapy. Because of its fast onset of action, Artecan 120 mg Injection is often used in emergency treatment to quickly reduce parasitemia (the number of parasites in the blood) and stabilize the patient.
Mechanism of Action
Artesunate, the active compound in Artecan, works by generating reactive oxygen species and free radicals once it is activated inside infected red blood cells. These reactive molecules damage key parasite proteins and membranes, leading to a breakdown of the parasite’s cellular structure and rapid parasite death. By swiftly reducing the parasite load in the bloodstream, artesunate helps lessen symptoms such as fever and chills and prevents progression to life-threatening complications like cerebral malaria, severe anemia, organ failure, and shock.
Indications and Uses
Artecan 120 mg Injection is primarily indicated for:
-
Severe or complicated malaria caused by P. falciparum
-
Cases where oral antimalarial therapy is unsuitable (e.g., vomiting, seizures, unconsciousness)
-
Initial emergency management followed by an appropriate full oral antimalarial course
-
Use when rapid parasite clearance is critical to survival
It is not typically used for malaria prevention (prophylaxis) or mild uncomplicated malaria managed with oral therapy.
Administration and Dosage
Artecan 120 mg Injection must be administered by a qualified healthcare provider in a clinical setting, as correct dosing and monitoring are vital. The injection can be given intravenously (IV) or intramuscularly (IM) depending on the patient’s clinical condition and urgency. Treatment usually begins with several doses spaced over 24 hours, and once the patient can tolerate oral medication, a full oral antimalarial course (such as an artemisinin-based combination therapy (ACT)) is completed to ensure complete parasite clearance and prevent recrudescence (recurrence).
Key Benefits
Artecan 120 mg Injection offers several clinical advantages:
-
Rapid parasite reduction, often within hours of the first dose
-
Improves survival rates in severe malaria compared with older antimalarials
-
Useful in patients who cannot take oral medication
-
A cornerstone of WHO-recommended treatment for severe malaria in many regions
Its use has significantly reduced malaria-related mortality, especially in areas with high transmission or drug-resistant parasite strains.
Side Effects and Safety Profile
While artesunate is generally well tolerated, some patients may experience side effects, which are usually mild and transient:
-
Headache
-
Dizziness or weakness
-
Gastrointestinal symptoms
-
Injection site pain or irritation
More serious but rare side effects can include changes in blood counts, liver or kidney function alterations, and delayed hemolysis (destruction of red blood cells) occurring days to weeks after treatment. Due to this risk, follow-up monitoring of blood counts is recommended.
Precautions and Contraindications
Before administering Artecan 120 mg Injection, healthcare professionals should consider:
-
Known allergy to artesunate or other artemisinin derivatives
-
Pregnancy or breastfeeding (malaria poses high risk, but treatment decisions weigh benefits vs. potential risks)
-
Liver or kidney impairment
-
Concurrent medications that may interact with antimalarials
Because artesunate can cause dizziness or weakness, patients should avoid activities requiring alertness until they know how the drug affects them.
Storage and Handling
Artecan 120 mg Injection should be stored in a cool, dry place away from direct sunlight and moisture. It must be kept out of reach of children and should only be handled and administered by trained healthcare personnel.
For detailed, internationally accepted guidance on the treatment of severe malaria, including the role of artesunate, see the World Health Organization’s malaria treatment guidelines:
https://www.who.int/teams/global-malaria-programme/treatment.
| Pack Size |
12 Injections ,24 Injections ,3 Injection ,6 Injection |
|---|
